Matches in SemOpenAlex for { <https://semopenalex.org/work/W133435351> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W133435351 endingPage "602" @default.
- W133435351 startingPage "598" @default.
- W133435351 abstract "Bristol-Myers Squibb Pharma Co is developing the tumor necrosis factor-alpha (TNF alpha) converting enzyme inhibitor BMS-561392 (DPC-333) for the potential treatment of diseases characterized by overproduction of TNF alpha, such as rheumatoid arthritis (RA). A phase IIa trial in RA patients had commenced by April 2001, and by October 2002, BMS-561392 was also under investigation for the potential treatment of inflammatory bowel disease." @default.
- W133435351 created "2016-06-24" @default.
- W133435351 creator A5003873222 @default.
- W133435351 creator A5076037101 @default.
- W133435351 date "2003-05-01" @default.
- W133435351 modified "2023-10-18" @default.
- W133435351 title "BMS-561392. Bristol-Myers Squibb." @default.
- W133435351 cites W1825467595 @default.
- W133435351 cites W1895946034 @default.
- W133435351 cites W1985763670 @default.
- W133435351 cites W1997614344 @default.
- W133435351 cites W2050243158 @default.
- W133435351 cites W2071885136 @default.
- W133435351 cites W2074881372 @default.
- W133435351 cites W2098767548 @default.
- W133435351 cites W2176899369 @default.
- W133435351 cites W2314052274 @default.
- W133435351 cites W2321453230 @default.
- W133435351 cites W2328587823 @default.
- W133435351 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12833656" @default.
- W133435351 hasPublicationYear "2003" @default.
- W133435351 type Work @default.
- W133435351 sameAs 133435351 @default.
- W133435351 citedByCount "7" @default.
- W133435351 countsByYear W1334353512013 @default.
- W133435351 countsByYear W1334353512015 @default.
- W133435351 countsByYear W1334353512018 @default.
- W133435351 countsByYear W1334353512019 @default.
- W133435351 countsByYear W1334353512022 @default.
- W133435351 crossrefType "journal-article" @default.
- W133435351 hasAuthorship W133435351A5003873222 @default.
- W133435351 hasAuthorship W133435351A5076037101 @default.
- W133435351 hasConcept C126322002 @default.
- W133435351 hasConcept C17991360 @default.
- W133435351 hasConcept C2777575956 @default.
- W133435351 hasConcept C2909065710 @default.
- W133435351 hasConcept C71924100 @default.
- W133435351 hasConceptScore W133435351C126322002 @default.
- W133435351 hasConceptScore W133435351C17991360 @default.
- W133435351 hasConceptScore W133435351C2777575956 @default.
- W133435351 hasConceptScore W133435351C2909065710 @default.
- W133435351 hasConceptScore W133435351C71924100 @default.
- W133435351 hasIssue "5" @default.
- W133435351 hasLocation W1334353511 @default.
- W133435351 hasOpenAccess W133435351 @default.
- W133435351 hasPrimaryLocation W1334353511 @default.
- W133435351 hasRelatedWork W1996208529 @default.
- W133435351 hasRelatedWork W2003239344 @default.
- W133435351 hasRelatedWork W2022360783 @default.
- W133435351 hasRelatedWork W2145764667 @default.
- W133435351 hasRelatedWork W2313909601 @default.
- W133435351 hasRelatedWork W2366628240 @default.
- W133435351 hasRelatedWork W2473401012 @default.
- W133435351 hasRelatedWork W2896139880 @default.
- W133435351 hasRelatedWork W4247887685 @default.
- W133435351 hasRelatedWork W2182383285 @default.
- W133435351 hasVolume "4" @default.
- W133435351 isParatext "false" @default.
- W133435351 isRetracted "false" @default.
- W133435351 magId "133435351" @default.
- W133435351 workType "article" @default.